Masimo

Masimo is a global medical technology company founded in 1989 by Joe Kiani. It has grown from a small start-up to a publicly traded company listed on NASDAQ under the ticker symbol MASI, employing over 7,000 people worldwide. The company focuses on improving patient outcomes and advancing noninvasive monitoring technologies. Masimo specializes in developing innovative noninvasive patient monitoring technologies, including medical devices and sensors. Its flagship product, the Masimo SET® pulse oximetry technology, accurately measures oxygen saturation in arterial blood, even in challenging conditions. The company also offers Masimo Hospital Automation™, which integrates its monitoring solutions into hospital systems to enhance patient care efficiency. Masimo's technologies are widely used in healthcare settings, helping clinicians monitor over 200 million patients annually.